BioEvis Hursever joined EW in 2011 as Vice President, was promoted to Principal in 2013 and to Partner in 2017. Dr. Hursever has played a key role on the Board of Directors of EW growth equity portfolio companies EUSA Pharma and Biotoscana. Prior to joining EW, Dr. Hursever had over 10 years of experience in the healthcare industry. She was a senior manager in the European life sciences and healthcare team at LEK Consul ....
Education